| | | | Western blot - Kallikrein 7 antibody - Catalytic domain (ab40953)  (enlarge) | |
| |
| Product Name | Kallikrein 7 antibody - Catalytic domain |
| | See all Kallikrein 7 antibodies (2)... |
| Product type | Primary antibodies |
| Description | Rabbit polyclonal to Kallikrein 7 - Catalytic domain |
| Immunogen | Synthetic peptide based on the catalytic domain of Human Kallikrein 7.
(Peptide available as ab43089.) |
| Reacts with (species key) | Hu |
| Specificity | Ab40953 reacts with human Kallikrein 7 and does not react with the other human kallikreins (hK1-6, 8-15). We have a range of domain specific antibodies for this target. For a full list please see all Kallikrein 7 antibodies |
| Tested applications (see key) | WB |
|
| Abreviews | |
|
| Application notes (see key) | Recommended dilutions WB: 1/1000 (when using colorimetric substrates such as BCIP/NBT) - 1/5000 (for chemiluminescent substrates). Predicted molecular weight: 27.6 kDa. A shorter sequence starting at the second methionine has been reported. The 181 amino acid protein has a predicted mass of 19.9 kDa. This shorter sequence, if produced as a protein, would lack the cysteine of the catalytic triad and is thus, likely to be proteolytically inactive. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user. |
| Cellular localization | Secreted |
| Research areas | Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> Kallikreins Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> Kallikreins Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> Kallikreins |
| Relevance | The human tissue Kallikrein gene family encodes 15 serine proteases. All Kallikreins share structural similarities including cysteine residues, a catalytic triad of His, Asp, and Ser residues, typically five coding exons and varied intron phases. Kallikreins are predominantly secreted as inactive zymogens prior to activation by cleavage of an N-terminal peptide and all function extracellularly. Kallikreins can be activated autocatalytically, via other Kallikreins, or additional proteases. While structurally similar, Kallikrein family members have distinct functions and have key roles in many physiological and pathological processes. Many human tissue Kallikreins also show promise as cancer biomarkers, which may facilitate earlier detection and characterization of many forms of cancer.
Kallikrein 7, also known as stratum corneum chymotryptic enzyme (SCCE) and PRSS6, is a chymotrypsin-like serine proteinase. Originally described from human skin as a serine protease involved in shedding of skin cells and remodeling if the skin, SCCE was later identified as Kallikrein 7. Kallikrein 7 is found at the highest levels in the skin, often complexed with the endogenous serpins SLPI or elafin and kallikrein 7 can be found complexed to a number of different proteinase inhibitors. In addition to skin, Kallikrein 7 has been found in the kidney, esophagus, neuronal tissues, amniotic fluid, saliva, breast milk, urine, synovial fluid, seminal plasma and serum. Kallikrein 7 has been reported to be decreased in the CSF of Alzheimer's patients and message levels of KLK7 were decreased in adenocarcinoma. In skin, overexpression of hK7 has been shown to cause a form of dermatitis and in psoriasis hK7 is expressed in higher levels than controls. The skin adhesive proteins corneodesmosin and desmocollin 1 have been reported to be substrates of Kallikrein 7, as is interleukin 1 and the insulin B-chain. |
| | |
| Database links | The links below go to external sites and will open in a new browser window |
| Raised in | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Purity | Immunogen affinity purified |
| Storage buffer | Preservative: 0.05% Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
| Form | Liquid |
| Concentration | 1.000 mg/ml |
| Storage instructions | Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. |
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Kallikrein 7 antibody - Catalytic domain is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| See below for Kallikrein 7 antibody - Catalytic domain images, references, products related to ab40953 and other tools. |
| |
Kallikrein 7 antibody - Catalytic domain images: |
Western blot - Kallikrein 7 antibody - Catalytic domain (ab40953) All lanes : Kallikrein 7 antibody - Catalytic domain (ab40953) at 1/1000 dilution
Lane 1 : Kallikrein 7 at 0.05 µg Lane 2 : Kallikrein 7 at 0.01 µg Lane 3 : Kallikrein 7 at 0.001 µg
Predicted band size : 27.6 kDa Observed band size : 32 kDa (why is the actual band size different from the predicted?) Additional bands at : 20 kDa (possible cleavage fragment). |
| |
| |
| Search PubMed (MEDLINE) for references to Kallikrein 7 |
| |
Kallikrein 7 antibody - Catalytic domain - more information |
Customer reviews (feedback) regarding Kallikrein 7 antibody - Catalytic domain |
Customer FAQs regarding Kallikrein 7 antibody - Catalytic domain |
Protocols for Kallikrein 7 antibody - Catalytic domain |
Price and availability of products related to Kallikrein 7 antibody - Catalytic domain |
| |
Kallikrein 7 antibody - Catalytic domain - related products: |
| |
| |
Kallikrein 7 antibody - Catalytic domain - other tools: |
Contact Abcam with a Technical Enquiry about Kallikrein 7 antibody - Catalytic domain |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"